Finance

Lists
Why is 600993 up 3.54%?
Dive Deeper
600993:SHA
Mayinglong Pharmaceutical Group Co Ltd
CN¥24.56
+3.54%
(+0.84) 1D
Oct 14, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600993...
Open
CN¥23.62
High
CN¥24.65
Low
CN¥23.60
Mkt. cap
10.22B
Avg. vol.
3.55M
Volume
11.59M
Dividend
2.85%
Quarterly dividend
CN¥0.18
Ex-dividend date
Aug 5, 2026
P/E ratio
17.62
52-wk high
CN¥30.18
52-wk low
CN¥21.22
EPS
CN¥1.39
Shares outstanding
431.05M
No. of employees
3K
Open
CN¥23.62
High
CN¥24.65
Low
CN¥23.60
Mkt. cap
10.22B
Avg. vol.
3.55M
Volume
11.59M
Dividend
2.85%
Quarterly dividend
CN¥0.18
Ex-dividend date
Aug 5, 2026
P/E ratio
17.62
52-wk high
CN¥30.18
52-wk low
CN¥21.22
EPS
CN¥1.39
Shares outstanding
431.05M
No. of employees
3K
News stories
From web sources and news partners
About Mayinglong Pharmaceutical Group Co Ltd
CEO-
Employees2.54K
Founded1582
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
888.26M
1.03B
1.01B
999.38M
Cost of goods sold
460.66M
521.28M
524.38M
546.24M
Cost of revenue
460.66M
521.28M
524.38M
546.24M
Research and development expenses
20.83M
19.99M
17.06M
14.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
232.34M
392.42M
219.69M
256.36M
Operating expense
252.95M
423.97M
243.25M
288.91M
Total operating expenses
713.61M
945.24M
767.64M
835.15M
Operating income
174.65M
84.08M
244.73M
164.22M
Other non operating income
6.84M
2.12M
-100.17K
-1.47M
EBT including unusual items
187.83M
100.89M
255.42M
187.60M
EBT excluding unusual items
200.49M
110.29M
253.57M
169.52M
Income tax expense
25.95M
14.42M
36.14M
29.69M
Effective tax rate
13.81%
14.30%
14.15%
15.83%
Other operating expenses
-8.32M
20.94M
4.28M
9.21M
Net income
157.79M
80.48M
212.59M
150.03M
Net profit margin
17.76%
7.82%
21.00%
15.01%
Earnings per share
-
-
-
-
Interest and investment income
20.70M
26.15M
10.03M
7.77M
Interest expense
-1.72M
-2.19M
-1.10M
-994.32K
Net interest expenses
18.99M
23.96M
8.94M
6.77M
Depreciation and amortization charges
-
-
-
-
EBITDA
185.56M
98.76M
259.41M
176.98M
Gain or loss from assets sale
-216.81K
89.70K
-
58.75K
AI content may include mistakes. Learn more
Google apps